Cephalon Inc – ‘8-K’ for 12/28/98

As of:  Monday, 12/28/98   ·   For:  12/28/98   ·   Accession #:  1036050-98-2183   ·   File #:  0-19119

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     10K 
 2: EX-99       Press Release                                          4     15K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549 

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) 
OF THE SECURITIES EXCHANGE ACT OF 1934

December 28, 1998 
----------------------------------------- 
(Date of earliest event reported) 

Cephalon, Inc.  
--------------------------------------------------------------------  
(Exact name of registrant as specified in its charter)  

                                                                [Download Table]


                                                                
       Delaware                          0-19119      23-2484489
-----------------------------------  -----------   -------------
(State or other jurisdiction         (Commission   (IRS Employer
of incorporation or organization)    File Number)  ID No.)      


145 Brandywine Parkway                                          
West Chester, Pennsylvania                     19380              
--------------------------                   -----------------    
(Address of principal executive offices)           (Zip Code)                   

(215) 344-0200
--------------------------------------------------------------------  
(Registrant's telephone number, including area code)

Not Applicable  
------------------------------------------------------------------------  
(Former name, former address and former fiscal year,  
if changed since last report) 

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.  OTHER EVENTS.                                                          

    On December 28, 1998, Cephalon, Inc. (the "Registrant") publicly announced
that the U.S. Food & Drug Administration (the "FDA") approved its drug          
PROVIGIL(R) (modafinil) Tablets [C-IV], for the treatment of excessive daytime  
sleepiness associated with Narcolepsy.                                          

    The Registrant hereby incorporates by reference the press release attached
hereto as Exhibit 99.1 and made a part hereof, into this Item 5.                

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.                                     

(a) Financial Statements of Business Acquired: None                   
------------------------------------------                    

(b) Pro Forma Financial Information: None                             
--------------------------------                              

 (c) Exhibits: Reference is made to the Exhibit Index annexed hereto and
--------                                                      
made a part hereof.                                                             

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES  
----------- 

  Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the        
undersigned thereunto duly authorized.                                          

      CEPHALON, INC.

Date: December 28, 1998          By: /s/ Bruce A. Peacock                       
-----------------              ------------------------------       
            Bruce A. Peacock
                        Executive Vice President and
                   Chief Operating Officer

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
EXHIBIT INDEX 
------------- 

EXHIBIT                                                           PAGE          
-------                                                           ----          

99.1           Press Release dated December 28, 1998                          

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		12/28/98		1		4			None on these Dates
									List all Filings